You have 5 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

zebinix

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Partial-onset Seizures With or Without Secondary Generalisation Trial in Seoul (Zebinix 400mg, Placebo for Zebinix 400mg,

Completed
  • Partial-onset Seizures With or Without Secondary Generalisation
  • Zebinix 400mg
  • +5 more
  • Seoul, Korea, Republic of
    Whan In Pharm.
Jan 6, 2020

ZEBinix® Retention Rate in Epilepsy in Elderly Patients

Unknown status
  • Epilepsy
  • +3 more
  • Zebinix
  • Lyon, France
    Centre Hospitalier St Joseph St Luc
Jan 7, 2020

ZEDEBAC: Zebinix Effects in Dependency of Baseline Conditions

Completed
  • Focal Epilepsy
    • Multiple Locations, Germany
      (unnamed)
    Sep 11, 2019

    Epilepsy Trial (Eslicarbazepine acetate (ESL))

    Completed
    • Epilepsy
    • Eslicarbazepine acetate (ESL)
    • (no location specified)
    Apr 12, 2017

    Eslicarbazepine Acetate as Add-On Treatment to One Baseline

    Completed
    • Epilepsy
    • Lisboa, Portugal
      Hospital Fernando da Fonseca
    Jan 5, 2017

    Epilepsy Trial in Worldwide (Eslicarbazepine Acetate)

    Completed
    Has Results
    • Epilepsy
    • Eslicarbazepine Acetate
    • Innsbruck, Austria
    • +47 more
    Jun 29, 2017

    Painful Diabetic Neuropathy Trial (Eslicarbazepine acetate, Placebo)

    Completed
    Has Results
    • Painful Diabetic Neuropathy
    • Eslicarbazepine acetate
    • Placebo
    • (no location specified)
    May 18, 2016

    Epilepsy Trial in Rennes (Eslicarbazepine acetate, Simvastatin)

    Completed
    Has Results
    • Epilepsy
    • Rennes, France
      Biotrial, 7-9 rue Jean-Louis Bertrand
    Jan 12, 2015

    Neuropathic Pain Trial in Mamede do Coronado (Metformin, Eslicarbazepine acetate)

    Completed
    Has Results
    • Neuropathic Pain
    • Mamede do Coronado, Portugal
      Human Pharmacology Unit (UFH)Section of Clinical Research (SIC),
    Dec 15, 2014

    Postherpetic Neuralgia Trial (Eslicarbazepine acetate, Placebo)

    Completed
    Has Results
    • Postherpetic Neuralgia
    • Eslicarbazepine acetate
    • Placebo
    • (no location specified)
    Oct 21, 2014

    Painful Diabetic Neuropathy Trial in S. Mamede do Coronado (Eslicarbazepine acetate (BIA 2-093), Placebo)

    Terminated
    Has Results
    • Painful Diabetic Neuropathy
    • Eslicarbazepine acetate (BIA 2-093)
    • Placebo
    • S. Mamede do Coronado, Portugal
      BIAL - Portela & Cª, S.A.
    Jul 17, 2014

    Refractory Partial Epilepsy Trial in S. Mamede do Coronado (eslicarbazepine acetate, )

    Completed
    Has Results
    • Refractory Partial Epilepsy
    • eslicarbazepine acetate
    • placebo
    • S. Mamede do Coronado, Portugal
      Bial - Portela & Cª, S.A.
    Jun 23, 2014

    Partial Epilepsy Trial in S. Mamede do Coronado (eslicarbazepine acetate, (Part I), ESL - Open-label Extension (Part II))

    Completed
    Has Results
    • Partial Epilepsy
    • eslicarbazepine acetate
    • +2 more
    • S. Mamede do Coronado, Portugal
      Bial - Portela & Cª, S.A.
    Jun 23, 2014

    Partial Epilepsy Trial in S. Mamede do Coronado (eslicarbazepine acetate, , ESL - Part II)

    Completed
    Has Results
    • Partial Epilepsy
    • eslicarbazepine acetate
    • +2 more
    • S. Mamede do Coronado, Portugal
      Bial - Portela & Cª, S.A.
    Jun 23, 2014

    Post Herpetic Neuralgia Trial in Berlin (Eslicarbazepine acetate (BIA 2-093), Placebo)

    Terminated
    Has Results
    • Post Herpetic Neuralgia
    • Eslicarbazepine acetate (BIA 2-093)
    • Placebo
    • Berlin, Germany
      Synexus ClinPharm GmbH
    Feb 26, 2014

    Retigabine for Adjunctive Therapy in Partial Epilepsy

    Completed
    • Epilepsy
    • (no location specified)
    Sep 12, 2013